← All organizations
University of Vermont

University of Vermont

Academic/HospitalWebsite ↗

Also known as: Beth Kirkpatrick | Clinical Science Research Unit, Department of Psychiatry, University of Vermont,1 South Prospect Street, Burlington, VT 05401 | Daniel L Lustgarten | David Lunardini | Department of Obstetrics, Gynecology and Reproductive sciences, Division of Reproductive Endocrinology and Infertility, University of Vermont College of Medicine, Burlington, VT, USA | Fletcher Allen Health Care & University of Vermont | Fletcher Allen Health Care, University of Vermont | Fletcher Allen Health Care / University of Vermont College of Medicine | James BOYD MD | Memory Center, Department of Psychiatry, University of Vermont College of Medicine | Pennington Biodmedical Research Center | Resident | Scott Potenta, MD, PhD | The University of Vermont Medical Center | The Vermont Lung Center at the University of Vermont | University of Vermont | University of Vermont and Pennington Biomedical Research Center | University of Vermont, Burlington | University of Vermont Department of Medicine | University of Vermont Department of Neurology | University of Vermont, Department of Psychiatry | University of Vermont/Feltcher Allen Health Care | University of Vermont/Fletcher Allen Healthcare | University of Vermont & Fletcher Allen Health Care | University of Vermont/Fletcher Allen Health Care,Inc. | University of Vermont Medical Center | University of Vermont Medical Center, Burlington (Vermont, USA) | University of Vermont Medical Center, Vermont | University of Vermont Multiple Sclerosis Center | University of Vermont & State Agricultural College | University of Vermont / United States Principal Investigator | University of Vermont Vaccine Testing Center | University of Vermont / Vermont Children's Hospital | UVM | UVM/FAHC | Vaccine Testing Center, University of Vermont College of Medicine

Highest phase reached

Phase 4

First clinical trial

Apr 1, 1983

Last known activity

Feb 1, 2026

Timeline

1970s

  1. Jan 1, 1971

    University of Vermont— Founded

Drugs by trial phase (188 distinct, 213 trials)

Indications

Studied for

Recent trials (50)

Details

Founded
Burlington, Vermont, US Jan 1, 1971
Last known activity
Feb 1, 2026